tiprankstipranks
Trending News
More News >
Merck KGaA (DE:MRK)
XETRA:MRK
Germany Market
Advertisement

Merck KGaA (MRK) Stock Forecast & Price Target

Compare
126 Followers
See the Price Targets and Ratings of:

MRK Analyst Ratings

Moderate Buy
10Ratings
Moderate Buy
7 Buy
1 Hold
2 Sell
Based on 10 analysts giving stock ratings to
Merck
KGaA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MRK Stock 12 Month Forecast

Average Price Target

€148.75
▲(31.87%Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Merck KGaA in the last 3 months. The average price target is €148.75 with a high forecast of €182.00 and a low forecast of €100.00. The average price target represents a 31.87% change from the last price of €112.80.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"99":"€99","120":"€120","141":"€141","162":"€162","183":"€183"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":182,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€182.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":148.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€148.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€100.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[99,120,141,162,183],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,112.4,117.75384615384615,123.10769230769232,128.46153846153845,133.81538461538463,139.16923076923078,144.52307692307693,149.87692307692308,155.23076923076923,160.5846153846154,165.93846153846152,171.2923076923077,176.64615384615385,{"y":182,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,112.4,115.19615384615385,117.99230769230769,120.78846153846155,123.58461538461539,126.38076923076923,129.1769230769231,131.97307692307692,134.76923076923077,137.56538461538463,140.36153846153846,143.15769230769232,145.95384615384614,{"y":148.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,112.4,111.44615384615385,110.49230769230769,109.53846153846155,108.58461538461539,107.63076923076923,106.67692307692307,105.72307692307693,104.76923076923077,103.81538461538462,102.86153846153846,101.90769230769232,100.95384615384616,{"y":100,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":149.288,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.243,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172.018,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":153.559,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.252,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":139.274,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.359,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.741,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.579,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.301,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":114.75,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.4,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€182.00Average Price Target€148.75Lowest Price Target€100.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DE:MRK
TipRanks AITipRanks
Not Ranked
TipRanks
€125
Buy
10.82%
Upside
Upgraded
07/09/25
Merck KGaA's overall stock score is driven by its strong financial performance and fair valuation. The company's robust profitability, efficient operations, and solid balance sheet underpin its financial health. Technical analysis suggests a slightly bearish trend, but the company's valuation remains reasonable. The absence of earnings call and corporate events data means these factors did not influence the score.
Stifel Nicolaus Analyst forecast on DE:MRK
Dylan Van HaaftenStifel Nicolaus
Stifel Nicolaus
€153€100
Sell
-11.35%
Downside
Downgraded
07/07/25
Merck KGaA (0O14) was downgraded to a Sell Rating at Stifel Nicolaus
UBS
Buy
Reiterated
07/01/25
UBS Keeps Their Buy Rating on Merck KGaA (0O14)
J.P. Morgan Analyst forecast on DE:MRK
Richard VosserJ.P. Morgan
J.P. Morgan
€155
Buy
37.41%
Upside
Reiterated
06/03/25
J.P. Morgan Reaffirms Their Buy Rating on Merck KGaA (0O14)
Deutsche Bank  Analyst forecast on DE:MRK
Falko FriedrichsDeutsche Bank
Deutsche Bank
€174
Buy
54.26%
Upside
Reiterated
05/30/25
Merck KGaA (0O14) Gets a Buy from Deutsche Bank
Bernstein
€168€147
Hold
30.32%
Upside
Reiterated
05/27/25
Bernstein Keeps Their Hold Rating on Merck KGaA (0O14)
Barclays
€160
Buy
41.84%
Upside
Reiterated
05/16/25
Barclays Reiterates Overweight Rating on Merck KGaA (MRK:GR) (MKGAF)Barclays analyst Emily Field reiterated an Overweight rating and EUR160.00 price target on Merck KGaA (MRK:GR) (OTC: MKGAF).
Goldman Sachs Analyst forecast on DE:MRK
James QuigleyGoldman Sachs
Goldman Sachs
€169€165
Buy
46.28%
Upside
Reiterated
05/16/25
Merck KGaA (0O14) Receives a Buy from Goldman Sachs
DZ BANK AG Analyst forecast on DE:MRK
Peter SpenglerDZ BANK AG
DZ BANK AG
Buy
Reiterated
05/15/25
DZ BANK AG Keeps Their Buy Rating on Merck KGaA (0O14)
Kepler Capital  Analyst forecast on DE:MRK
David EvansKepler Capital
Kepler Capital
€182
Buy
61.35%
Upside
Reiterated
05/15/25
Kepler Capital Keeps Their Buy Rating on Merck KGaA (0O14)
Exane BNP Paribas Analyst forecast on DE:MRK
Peter VerdultExane BNP Paribas
Exane BNP Paribas
€107
Sell
-5.14%
Downside
Initiated
04/16/25
BNP Paribas Exane Starts Merck KGaA (MRK:GR) (MKGAF) at UnderperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Merck KGaA (MRK:GR) (OTC: MKGAF) with a Underperform rating and a price target of EUR107.00.
Morgan Stanley Analyst forecast on DE:MRK
Thibault BoutherinMorgan Stanley
Morgan Stanley
€190€160
Hold
41.84%
Upside
Downgraded
02/12/25
Morgan Stanley Downgrades Merck KGaA (MRK:GR) (MKGAF) to EqualweightMorgan Stanley analyst Thibault Boutherin downgraded Merck KGaA (MRK:GR) (OTC: MKGAF) from Overweight to Equalweight with a price target of EUR160.00 (from EUR190.00).
Jefferies Analyst forecast on DE:MRK
Brian BalchinJefferies
Jefferies
Buy
Reiterated
01/21/25
Jefferies Keeps Their Buy Rating on Merck KGaA (0O14)
BMO Capital Analyst forecast on DE:MRK
Evan SeigermanBMO Capital
BMO Capital
€128.31
Buy
13.75%
Upside
Reiterated
10/23/24
BMO Capital Sticks to Their Buy Rating for Merck KGaA (0O14)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DE:MRK
TipRanks AITipRanks
Not Ranked
TipRanks
€125
Buy
10.82%
Upside
Upgraded
07/09/25
Merck KGaA's overall stock score is driven by its strong financial performance and fair valuation. The company's robust profitability, efficient operations, and solid balance sheet underpin its financial health. Technical analysis suggests a slightly bearish trend, but the company's valuation remains reasonable. The absence of earnings call and corporate events data means these factors did not influence the score.
Stifel Nicolaus Analyst forecast on DE:MRK
Dylan Van HaaftenStifel Nicolaus
Stifel Nicolaus
€153€100
Sell
-11.35%
Downside
Downgraded
07/07/25
Merck KGaA (0O14) was downgraded to a Sell Rating at Stifel Nicolaus
UBS
Buy
Reiterated
07/01/25
UBS Keeps Their Buy Rating on Merck KGaA (0O14)
J.P. Morgan Analyst forecast on DE:MRK
Richard VosserJ.P. Morgan
J.P. Morgan
€155
Buy
37.41%
Upside
Reiterated
06/03/25
J.P. Morgan Reaffirms Their Buy Rating on Merck KGaA (0O14)
Deutsche Bank  Analyst forecast on DE:MRK
Falko FriedrichsDeutsche Bank
Deutsche Bank
€174
Buy
54.26%
Upside
Reiterated
05/30/25
Merck KGaA (0O14) Gets a Buy from Deutsche Bank
Bernstein
€168€147
Hold
30.32%
Upside
Reiterated
05/27/25
Bernstein Keeps Their Hold Rating on Merck KGaA (0O14)
Barclays
€160
Buy
41.84%
Upside
Reiterated
05/16/25
Barclays Reiterates Overweight Rating on Merck KGaA (MRK:GR) (MKGAF)Barclays analyst Emily Field reiterated an Overweight rating and EUR160.00 price target on Merck KGaA (MRK:GR) (OTC: MKGAF).
Goldman Sachs Analyst forecast on DE:MRK
James QuigleyGoldman Sachs
Goldman Sachs
€169€165
Buy
46.28%
Upside
Reiterated
05/16/25
Merck KGaA (0O14) Receives a Buy from Goldman Sachs
DZ BANK AG Analyst forecast on DE:MRK
Peter SpenglerDZ BANK AG
DZ BANK AG
Buy
Reiterated
05/15/25
DZ BANK AG Keeps Their Buy Rating on Merck KGaA (0O14)
Kepler Capital  Analyst forecast on DE:MRK
David EvansKepler Capital
Kepler Capital
€182
Buy
61.35%
Upside
Reiterated
05/15/25
Kepler Capital Keeps Their Buy Rating on Merck KGaA (0O14)
Exane BNP Paribas Analyst forecast on DE:MRK
Peter VerdultExane BNP Paribas
Exane BNP Paribas
€107
Sell
-5.14%
Downside
Initiated
04/16/25
BNP Paribas Exane Starts Merck KGaA (MRK:GR) (MKGAF) at UnderperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Merck KGaA (MRK:GR) (OTC: MKGAF) with a Underperform rating and a price target of EUR107.00.
Morgan Stanley Analyst forecast on DE:MRK
Thibault BoutherinMorgan Stanley
Morgan Stanley
€190€160
Hold
41.84%
Upside
Downgraded
02/12/25
Morgan Stanley Downgrades Merck KGaA (MRK:GR) (MKGAF) to EqualweightMorgan Stanley analyst Thibault Boutherin downgraded Merck KGaA (MRK:GR) (OTC: MKGAF) from Overweight to Equalweight with a price target of EUR160.00 (from EUR190.00).
Jefferies Analyst forecast on DE:MRK
Brian BalchinJefferies
Jefferies
Buy
Reiterated
01/21/25
Jefferies Keeps Their Buy Rating on Merck KGaA (0O14)
BMO Capital Analyst forecast on DE:MRK
Evan SeigermanBMO Capital
BMO Capital
€128.31
Buy
13.75%
Upside
Reiterated
10/23/24
BMO Capital Sticks to Their Buy Rating for Merck KGaA (0O14)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Merck KGaA

1 Month
xxx
Success Rate
30/52 ratings generated profit
58%
Average Return
+1.08%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.69% of your transactions generating a profit, with an average return of +1.08% per trade.
3 Months
xxx
Success Rate
19/30 ratings generated profit
63%
Average Return
+4.59%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 63.33% of your transactions generating a profit, with an average return of +4.59% per trade.
1 Year
Peter SpenglerDZ BANK AG
Success Rate
19/30 ratings generated profit
63%
Average Return
+10.67%
reiterated a buy rating 2 months ago
Copying Peter Spengler's trades and holding each position for 1 Year would result in 63.33% of your transactions generating a profit, with an average return of +10.67% per trade.
2 Years
xxx
Success Rate
19/30 ratings generated profit
63%
Average Return
+20.49%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 63.33% of your transactions generating a profit, with an average return of +20.49% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MRK Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
0
1
5
5
4
Buy
19
18
22
15
11
Hold
3
4
4
3
1
Sell
0
1
1
1
1
Strong Sell
0
0
0
0
0
total
22
24
32
24
17
In the current month, MRK has received 15 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. MRK average Analyst price target in the past 3 months is 148.75.
Each month's total comprises the sum of three months' worth of ratings.

MRK Financial Forecast

MRK Earnings Forecast

Next quarter’s earnings estimate for MRK is €2.17 with a range of €2.13 to €2.25. The previous quarter’s EPS was €2.12. MRK beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.15% of the time in the same period. In the last calendar year MRK has Outperformed its overall industry.
Next quarter’s earnings estimate for MRK is €2.17 with a range of €2.13 to €2.25. The previous quarter’s EPS was €2.12. MRK beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.15% of the time in the same period. In the last calendar year MRK has Outperformed its overall industry.

MRK Sales Forecast

Next quarter’s sales forecast for MRK is €5.36B with a range of €5.28B to €5.43B. The previous quarter’s sales results were €5.28B. MRK beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.53% of the time in the same period. In the last calendar year MRK has Outperformed its overall industry.
Next quarter’s sales forecast for MRK is €5.36B with a range of €5.28B to €5.43B. The previous quarter’s sales results were €5.28B. MRK beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.53% of the time in the same period. In the last calendar year MRK has Outperformed its overall industry.

MRK Stock Forecast FAQ

What is DE:MRK’s average 12-month price target, according to analysts?
Based on analyst ratings, Merck KGaA’s 12-month average price target is 148.75.
    What is DE:MRK’s upside potential, based on the analysts’ average price target?
    Merck KGaA has 31.87% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Merck KGaA a Buy, Sell or Hold?
          Merck KGaA has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 1 hold ratings and 2 sell ratings.
            What is Merck KGaA’s share price target?
            The average share price target for Merck KGaA is 148.75. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €182.00 ,and the lowest forecast is €100.00. The average share price target represents 31.87% Increase from the current price of €112.8.
              What do analysts say about Merck KGaA?
              Merck KGaA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of Merck KGaA?
                To buy shares of DE:MRK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis